James F. Reddoch - Net Worth and Insider Trading
James F. Reddoch Net Worth
The estimated net worth of James F. Reddoch is at least $27 Million dollars as of 2025-05-07. James F. Reddoch is the EVP & Chief Scientific Officer of Royalty Pharma PLC and owns about 845,830 shares of Royalty Pharma PLC (RPRX) stock worth over $27 Million. Details can be seen in James F. Reddoch's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James F. Reddoch has not made any transactions after 2022-09-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James F. Reddoch
James F. Reddoch Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James F. Reddoch owns 1 companies in total, including Royalty Pharma PLC (RPRX) .
Click here to see the complete history of James F. Reddoch’s form 4 insider trades.
Insider Ownership Summary of James F. Reddoch
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| RPRX | Royalty Pharma PLC | 2022-09-28 | EVP & Research & Investments |
James F. Reddoch Latest Holdings Summary
James F. Reddoch currently owns a total of 1 stock. James F. Reddoch owns 845,830 shares of Royalty Pharma PLC (RPRX) as of September 28, 2022, with a value of $27 Million.
Latest Holdings of James F. Reddoch
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RPRX | Royalty Pharma PLC | 2022-09-28 | 845,830 | 32.46 | 27,455,642 |
Holding Weightings of James F. Reddoch
James F. Reddoch Form 4 Trading Tracker
According to the SEC Form 4 filings, James F. Reddoch has made a total of 13 transactions in Royalty Pharma PLC (RPRX) over the past 5 years, including 0 buys and 13 sells. The most-recent trade in Royalty Pharma PLC is the sale of 100,000 shares on September 28, 2022, which brought James F. Reddoch around $4 Million.
Insider Trading History of James F. Reddoch
- 1
James F. Reddoch Trading Performance
James F. Reddoch Ownership Network
Ownership Network List of James F. Reddoch
Ownership Network Relation of James F. Reddoch
James F. Reddoch Owned Company Details
What does Royalty Pharma PLC do?
Who are the key executives at Royalty Pharma PLC?
James F. Reddoch is the EVP & Research & Investments of Royalty Pharma PLC. Other key executives at Royalty Pharma PLC include 10 percent owner Avara Management Ltd , EVP & CFO Terrance P. Coyne , and director & CEO & Chairman of the Board Pablo G. Legorreta .
Royalty Pharma PLC (RPRX) Insider Trades Summary
Over the past 18 months, James F. Reddoch made no insider transaction in Royalty Pharma PLC (RPRX). Other recent insider transactions involving Royalty Pharma PLC (RPRX) include a net sale of 934,197 shares made by Avara Management Ltd , and a net sale of 470,000 shares made by Rory B Riggs .
In summary, during the past 3 months, insiders sold 0 shares of Royalty Pharma PLC (RPRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,404,197 shares of Royalty Pharma PLC (RPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,404,197 shares.
Royalty Pharma PLC (RPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Royalty Pharma PLC Insider Transactions
James F. Reddoch Mailing Address
Above is the net worth, insider trading, and ownership report for James F. Reddoch. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, James F. Reddoch's mailing address is: New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
